SCHEMBL20426904

SCHEMBL20426904

CC(C)c1ccc2cc[nH]c2c1-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ CHUK O15111 1/20 0.35
▸ AHR P35869 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ AXL P30530 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ BRD4 O60885 1/20 0.32
▸ GCGR P47871 1/20 0.32
▸ CCNE2 O96020 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ CCNE1 P24864 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ ADORA3 P0DMS8 2/20 0.31
▸ ADORA2A P29274 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134144 0.75 GABRA1 (0.42) GCGR
SCHEMBL31438285 0.74 AHR (0.50) NPC1IKBKBCHUKAHRKEAP1
SCHEMBL22792384 0.73 TNF (0.37) AHRKEAP1BCHETNFRIPK1
SCHEMBL16746099 0.73 TNF (0.37) AHRKEAP1BCHETNFRIPK1
SCHEMBL6140775 0.72 MAPT (0.43) —
SCHEMBL16088044 0.72 EIF4A3 (0.47) AHRKEAP1BCHETNFRIPK1
SCHEMBL3686667 0.72 MAPT (0.41) NPC1AHRKDM4EADORA1
SCHEMBL2611040 0.71 AHR (0.50) AHRKEAP1BCHEBRD4
SCHEMBL23877944 0.70 IKBKB (0.44) NPC1IKBKBCHUKAHRKEAP1
SCHEMBL15833732 0.69 GABRA1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU NPC1 2684/4885IKBKB 3424/4885CHUK 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback